E-in-Singapore robot features faster and more comfortable COVID-19 swabbing

Singapore – A group of clinicians from the National Cancer Centre Singapore (NCCS), Singapore General Hospital (SGH) and Duke-NUS Medical School has partnered Biobot Surgical Pte Ltd, one of Singapore’s pioneers in the field of medical robotics technology, to develop a robot that automates nasal swabbing needed to diagnose COVID-19. Nasal swab is the preferred method of gathering the specimen as it gives the best yield for processing by laboratory.

Known as SwabBot™, the robot was born to help address the limitations of manual COVID-19 swabbing by reducing swabbers’ risk of exposure to the virus, reducing the need for trained manpower, standardising the consistency of swabs taken and providing greater throughput of swab tests, as the robot does not suffer from fatigue and remains efficient throughout the day. Overall, the duration of the test is just 20 seconds from start to finish.

The project was initiated in April 2020, by

Read More